Nabriva Therapeutics AG ADR buy melinda
Start price
19.09.17
/
50%
?9.37
Target price
19.10.17
€11.73
Performance (%)
-36.18%
End price
19.10.17
€5.98
Summary
This prediction ended on 19.10.17 with a price of €5.98. The BUY prediction by melinda for Nabriva Therapeutics AG ADR performed very badly with a performance of -36.18%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nabriva Therapeutics AG ADR | - | - | - | - |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by melinda for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
Nabriva
DUBLIN - Die Aktien der Nabriva Therapeutics boomen heute Morgen , nachdem das Unternehmen experimentelle Antibiotikum für die in der Gemeinschaft (CABP) erworben bakterielle Pneumonie Behandlung hat die Bewertungskriterien erfüllt in einer Schlüsselphase III - Studie.
(Vom Mitglied beendet)
Stopped prediction by melinda for Nabriva Therapeutics AG ADR
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?2.54
14.03.19
14.03.19
€4.51
04.11.19
04.11.19
0.00%
04.11.19
04.11.19
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?5.99
19.10.17
19.10.17
€7.67
20.02.18
20.02.18
-17.17%
20.02.18
20.02.18
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?6.64
19.10.17
19.10.17
€8.50
20.02.18
20.02.18
-17.17%
20.02.18
20.02.18
Nabriva Therapeutics AG ADR
Start price
Target price
Perf. (%)
?8.75
11.05.17
11.05.17
€10.37
17.05.17
17.05.17
4.59%
17.05.17
17.05.17